Both in Pharmaceuticals
Omeros vs Mannkind
Over the past year OMER returned +99.9% and MNKD returned −44.4%; their daily moves had a correlation of 0.06.
OMER +99.9% MNKD −44.4%Growth of $1, one year, split-adjusted
| Metric | OMER | MNKD |
|---|---|---|
| Price | $16.20 | $3.04 |
| Market cap | $1.17B | $977.5M |
| Today | −13.78% | −4.70% |
| 1 month | −12.2% | −15.1% |
| 6 months | +20.5% | +7.0% |
| Year to date | −5.7% | −46.4% |
| 1 year | +55.5% | −41.9% |
| Revenue growth (YoY) | — | +42.9% |
| Gross margin | 97.2% | 73.0% |
| Net margin | 46.4% | −17.4% |
| P/E (TTM) | 9.4× | — |
| Price / sales | 30.5× | 2.5× |
| Net cash | $58.7M | -$373.9M |
| Dividend yield | — | — |
| Volatility (60d) | 81.2% | 61.9% |
| Short % of float | 17.7% | 8.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).